Changhai Hospital: Pancreatic Neoplasms trials
The registry lists 32 Pancreatic Neoplasms studies with Changhai Hospital as lead sponsor. 20 are open to participants now and 2 have results posted.
Phase 1 4Phase 2 10Phase 3 3No phase 17(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic PancreatitisNot yet recruitingNCT07762950
- Neoadjuvant HRS-4642 Plus Chemotherapy With or Without Immunotherapy for Pancreatic CancerNot yet recruitingNCT07691593Phase 2
- Immune Repertoire Decoding for Chronic Pancreatitis-to-Pancreatic Cancer Risk StratificationNot yet recruitingNCT07612566
- AI-Powered Precision Decision-Making for Pancreatic DiseasesRecruitingNCT07439757
- CAR-NK Cells (CL-NK-003) in Pancreatic CancerRecruitingNCT07425483Phase 1
- Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic CancerRecruitingNCT07117045
- CAR-NK Cells (CL-NK-001) in Pancreatic CancerRecruitingNCT06816823Phase 1
- AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening CohortRecruitingNCT06638866
- Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)RecruitingNCT06427460Phase 2
- Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)RecruitingNCT06427447Phase 3
- Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic PancreatitisRecruitingNCT06411470
- Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOXNot yet recruitingNCT06210360Phase 2
- Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic CarcinomaRecruitingNCT05869474Not applicable
- SBRT Plus vNKT for Pancreatic CancerRecruitingNCT05783076Phase 2
- Organoid-Guided Chemotherapy for Advanced Pancreatic CancerRecruitingNCT04931381Phase 3
- Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)RecruitingNCT04743479
- Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic CancerRecruitingNCT04536220
- Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic CancerRecruitingNCT04324307Phase 1/2
- Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic CancerRecruitingNCT04146298Phase 1/2
- Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1RecruitingNCT03777462Phase 2
- SBRT Plus Pembrolizumab and Trametinib for Pancreatic CancerCompletedNCT02704156Phase 2Results posted
- Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic CancerCompletedNCT02704143Not applicableResults posted
- Pancreatic Disease Burden in Older Adults (1990-2040)CompletedNCT07177599
- Prediction Model of Pancreatic Neoplasms in CP Patients With Focal Pancreatic LesionsCompletedNCT07045181
- Statin Addition to Chemotherapy for Advanced Pancreatic CancerCompletedNCT06241352Phase 2
- iDentification and vAlidation Model of Liquid biopsY Based cfDNA Methylation and pRotEin biomArKers for Pancreatic Cancer (DAYBREAK Study)Status unknownNCT05495685
- Organoid-Guided Adjuvant Chemotherapy for Pancreatic CancerCompletedNCT04931394Phase 3
- Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Recurrent Pancreatic CancerStatus unknownNCT04902261Phase 2
- Personalized Precision Diagnosis and Treatment of Pancreatic CancerStatus unknownNCT04373928Not applicable
- EUS-guided Celiac Plexus Neurolysis for the Treatment of Abdominal Pain in Pancreatic CancerStatus unknownNCT03940027Not applicable
- Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic CancerActive, not recruitingNCT02745847Not applicable
- Phase ǀ Study on Pancreatic Cancer Treated by CyberKnifeCompletedNCT02716207Not applicable